Shinya Osone
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Successful Treatment of Refractory Pediatric TAFRO Syndrome With Combination Chemotherapy: A Case Report.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: August 22, 2025
Hearing loss in Langerhans cell histiocytosis: close association with central nervous system consequences.
Journal: International journal of hematology
Published: July 28, 2025
Hemostatic Dynamics Mainly Based on Hypofibrinolysis During Early-Phase Interfant-Type Chemotherapy in Three Infants with Acute Lymphoblastic Leukemia: Results from Japan Children's Cancer Group ThrombALL-MLL-17.
Journal: Pediatric blood & cancer
Published: November 14, 2024
Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells.
Journal: Cancer immunology, immunotherapy : CII
Published: August 04, 2024
Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study.
Journal: International journal of hematology
Published: September 15, 2023
Allogeneic Hematopoietic Cell Transplantation With Reduced Toxicity Conditioning for Pediatric B Lymphoid Malignancy.
Journal: Journal of pediatric hematology/oncology
Published: August 18, 2023
Inter-reporter differences in symptom burdens in Japanese children with cancer.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: April 18, 2023
Leukaemic cells expressing ETV6::FRK are sensitive to dasatinib in vivo.
Journal: EJHaem
Published: February 16, 2023
Current methods of preventing infectious disease and managing febrile neutropenia in childhood cancer patients: a nationwide survey in Japan.
Journal: International journal of clinical oncology
Published: September 13, 2022
Clinical and Genetic Characterization of Patients with Artemis Deficiency in Japan.
Journal: Journal of clinical immunology
Published: August 18, 2022
Targeting FLT3-specific chimeric antigen receptor T cells for acute lymphoblastic leukemia with KMT2A rearrangement.
Journal: Cancer immunology, immunotherapy : CII
Published: August 02, 2022
Last Updated: 09/26/2026